9 completed, 2 terminated, 1 not yet recruiting, 1 withdrawn. 5 Not applicable, 4 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 4, Not yet recruiting 1 |
| Phase 2 | 4 | Completed 3, Terminated 1 |
| Phase 1 | 2 | Completed 1, Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Allodynia: new trials by email Literature Review of Allodynia trials Research Report on Allodynia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Music Therapy During Hypothermia in the NICU Live entrained music therapy - Music Therapy, Pain | Not applicable | Not yet recruiting | Fundación Santa Fe de Bogota | 22 | 2025-10-30 | 2025-09-23 |
| GentleCath Air (Urinary Self-catheterization) - Pain in Female Patients With Neurological Vesico-sphincter Disorders GentleCath™ Air catheter - Spinal Cord Injuries, Multiple Sclerosis | Withdrawn | ConvaTec Inc. | 2021-05-31 | 2022-10-07 | ||
| Pain Response to Cannabidiol in Opioid-induced Hyperalgesia, Acute Nociceptive Pain and Allodynia By Using a Model Mimicking Acute Pain in Healthy Adults CBD, Placebo, Remifentanil - Acute Nociceptive Pain, Hyperalgesia | Not applicable | Completed | University Hospital, Basel, Switzerland | 21 | 2020-05-26 | 2020-10-19 |
| Pain Response to Cannabidiol in Induced Acute Nociceptive Pain, Allodynia and Hyperalgesia By Using a Model Mimicking Acute Pain in Healthy Adults CBD 800 mg p.o, Placebo p.o - Pain Sensation, Hyperalgesia | Not applicable | Completed | University Hospital, Basel, Switzerland | 20 | 2019-09-16 | 2020-01-29 |
| Comparison of Postoperative Nociception Between NOL-guided and Standard Intraoperative Analgesia Based on Fentanyl fentanyl NOL guided - Pain, Postoperative, Opioid Use | Not applicable | Completed | Victor Contreras, MSN | 100 | 2019-03-15 | 2022-03-08 |
| Can DFN-15 Terminate Migraine With Allodynia? DFN-15, Placebo - Migraine With Aura, Migraine Without Aura | Phase 2 | Completed | Hartford Hospital | 51 | 2018-05-09 | 2019-04-16 |
| Evaluation of the Efficacy of Somatosensory Rehabilitation of Pain by Vibrotactile Stimulation on Static Mechanical Allodynia Standard Medical treatment, Vibrotactile stimulation, Sham Stimulation with Vibradol device switched off - Allodynia | Not applicable | Completed | CRRF La Châtaigneraie | 17 | 2015-10-01 | 2020-11-12 |
| Fenobam on Heat/Capsaicin Induced Hyperalgesia in Healthy Volunteers Fenobam, Placebo - Hyperalgesia, Allodynia | Phase 1 | Completed | Laura Cavallone | 33 | 2014-01-01 | 2016-04-29 |
| Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MS Botulinum Toxin Type A, Normal Saline for Injection - Neuropathic Pain, Allodynia | Phase 2 | Terminated | University of Manitoba | 12 | 2013-10-01 | 2015-10-02 |
| Evaluation of the Antihyperalgesic Effect of Tapentadol in Two Human Experimental Models Tapentadol immediate release, placebo - Pain, Hyperalgesia | Phase 1 | Terminated | University Hospital Schleswig-Holstein | 24 | 2012-10-01 | 2022-09-14 |
| Botulinum Toxin Type A in Treatment of Cranial Allodynia in Patients With Headache Botulinum toxin type A, 0,9% saline - Headache, Allodynia | Phase 3 | Completed | Federal University of Bahia | 40 | 2010-12-01 | 2011-05-23 |
| Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan/Lidocaine Combination Clinical Trial Dextromethorphan, Lidocaine, Placebo (Dextromethorphan) - Central Neuropathic Pain, Allodynia | Phase 2 | Completed | Brigham and Women's Hospital | 26 | 2003-04-01 | 2025-12-08 |
| Clinical Neuropharmacology of Pain in Spinal Cord Injury- Dextromethorphan Dose Response Clinical Trial Dextromethorphan - Central Neuropathic Pain, Allodynia | Phase 2 | Completed | Brigham and Women's Hospital | 26 | 2003-04-01 | 2025-12-08 |
Hyperalgesia (13) · Pain (4) · Spinal Cord Injuries (3) · Agnosia (2) · Chronic Pain (2) · Headache (1) · Migraine with Aura (1) · Migraine without Aura (1) · Multiple Sclerosis (1) · Neuralgia (1) · Nociceptive Pain (1) · Pain, Postoperative (1) · Parkinsonian Disorders (1) · Urinary Bladder, Neurogenic (1)
Nervous System Diseases (13) · Neurologic Manifestations (13) · Pathological Conditions, Signs and Symptoms (13) · Sensation Disorders (13) · Signs and Symptoms (13) · Somatosensory Disorders (13) · Central Nervous System Diseases (4) · Pain (4) · Spinal Cord Diseases (3) · Trauma, Nervous System (3) · Wounds and Injuries (3) · Brain Diseases (2) · Neurobehavioral Manifestations (2) · Perceptual Disorders (2) · Autoimmune Diseases (1)
Botulinum Toxins, Type A (2) · Dextromethorphan (2) · Celecoxib (1) · Injections (1) · Lidocaine (1) · Remifentanil (1) · Saline Solution (1) · Tapentadol (1) · fenobam (1)
Brigham and Women's Hospital (2) · University Hospital, Basel, Switzerland (2) · CRRF La Châtaigneraie (1) · ConvaTec Inc. (1) · Federal University of Bahia (1) · Fundación Santa Fe de Bogota (1) · Hartford Hospital (1) · Laura Cavallone (1) · University Hospital Schleswig-Holstein (1) · University of Manitoba (1) · Victor Contreras, MSN (1)
United States (4) · Switzerland (2) · Brazil (1) · Canada (1) · Chile (1) · Colombia (1) · France (1) · Germany (1)
Christine N. Sang, MD, MPH (2) · Karen Ethans, MD (1) · Laura F Cavallone, M.D. (1) · Ralf Baron, Professor (1) · Rania Belmahfoud, MD (1) · Tobias Schneider, Dr. med (1) · Tobias Schneider, MD (1)
PMID 19402781, PMID 21620344, PMID 23945010, PMID 26247858, PMID 27295489, PMID 34086631, PMID 35239547
2019 (2), R01NS041503 (2)